Supplementary Methods, Tables 1 - 6, Figures 1 - 3, PRISMA Checklist from Diagnostic and Prognostic Value of microRNA-21 in Colorectal Cancer: An Original Study and Individual Participant Data Meta-analysis

Honghe Zhang,Peiwei Li,Haixing Ju,Martin Pesta,Vlastimil Kulda,Wenjun Jin,Mao Cai,Changbao Liu,Han Wu,Jinming Xu,Yao Ye,Guanglin Zhang,Enping Xu,Jianting Cai,Maode Lai,Dajing Xia,Jun Yang,Yihua Wu

DOI: https://doi.org/10.1158/1055-9965.22438171

2023-01-01

Abstract:Supplementary Table 1 Instrument used for the evaluation of the risk of bias and applicability concerns of the included prognostic studies (adapted from QUADAS-2). Supplementary Table 2 Characteristics of studies included in the diagnostic meta-analysis. Supplementary Table 3 Characteristics of studies included in the prognostic meta-analysis. Supplementary Table 4 Quality assessment of the included diagnostic studies according to QUADAS-2. Supplementary Table 5 Risk of bias and applicability concerns of included prognostic studies. Supplementary Table 6 Methodological quality of included prognostic studies according to STROBE criteria. Supplementary Figure 1 Receiver operating characteristic curves of plasma miR-21 for discrimination CRC patients from controls. Supplementary Figure 2 Kaplan–Meier curve of tissue miR-21 expression in relation to the survival of CRC patients in the original study. Supplementary Figure 3 Funnel plots of the meta-analyses (A) Funnel plot of tissue miR-21 and CRC OS (B) Funnel plot of tissue miR-21 and CRC DFS (3) Funnel plot of circulating miR-21 and CRC diagnosis. PRISMA Checklist.